Results 61 to 70 of about 4,474 (198)

Endoscopic closure of gastrocutaneous fistula with an AMPLATZER^TM septal occluder device [PDF]

Therapeutic Advances in Gastroenterology, 2015
Gastrocutaneous fistulas are rare and difficult to treat complications with an incidence of 1.7–4% in patients who have undergone bariatric surgery, and are associated with high morbidity and mortality rates with difficult management problems [Nguyen et al. 2001].
BEYAZIT, YAVUZ, Kayacetin, Ertugrul, Torun, Serkan, Odemis, Bulent   +3 more
openaire   +4 more sources

Simultaneous Repair of Iatrogenic Left Atrial and Aortic Perforations Using Ductus Arteriosus Occluders: A Case Report

Catheterization and Cardiovascular Interventions, Volume 107, Issue 2, Page 524-526, February 1, 2026.
ABSTRACT Iatrogenic perforation of the left atrium and aorta during transseptal puncture (TSP) is a rare but potentially life‐threatening complication. This report presents the case of an elderly male patient with a 20‐year history of atrial fibrillation who experienced this complication during a scheduled left atrial appendage closure procedure ...
Zhihao Wu, Shumin Ouyang, Minqi Liao, Lihua Chen, Haixian Yin, Jianping Zhou, Suxia Guo   +6 more
wiley   +1 more source

The Safety and Efficacy of Absnow Fully Biodegradable Atrial Septal Defect Occluder: A Prospective, Single‐Center Phase III Clinical Trial

Clinical Cardiology, Volume 49, Issue 2, February 2026.
ABSTRACT Objective To evaluate the safety, short‐term and mid‐term occlusion performance of the Absnow fully biodegradable atrial septal occluder in pediatric patients. Background The Absnow Occluder, an innovative fully biodegradable closure for ASD, has shown its safety and effectiveness in initial animal studies and preclinical trials.
Shiqiang Fan, Ying Xie, Zhenheng Ou, Piaohong Liang, Wei Wang, Meng Li, Cong Liu, Boning Li   +7 more
wiley   +1 more source

Septal Occluder in children and adults with atrial septal defects

, 2013
OBJECTIVES: In this study, we report the first experiences with the GORE(®) Septal Occluder in transcatheter treatment of patients with atrial septal defects (ASD).METHODS: Twenty-two patients with secundum ASD were selected for GORE(®) Septal Occluder ...
Nyboe, Camilla, Hjortdal, Vibeke E, Nielsen-Kudsk, Jens Erik, Vibeke E. Hjortdal, Camilla Nyboe, Jens Erik Nielsen‐Kudsk   +5 more
core   +1 more source

Percutaneous device closure of atrial septal defect in HIV-positive patient: a challenge for interventionist

HIV & AIDS Review. International Journal of HIV-Related Problems, 2020
Atrial septal defect (ASD) is one of the most common congenital heart defects. Intracardiac repair via midline sternotomy or right thoracotomy and cardiopulmonary bypass have been considered the standard treatment for the closure of atrial septal defects,
Natraj Setty H.S., M.C. Yeriswamy, Veeresh Patil, Jayashree Kharge, T.R. Raghu, P.C. Raghavendra, Rahul Patil, B.K. Geetha, C.N. Manjunath   +8 more
doaj   +1 more source

Safety and Feasibility of a Novel Split Design Left Atrial Appendage Occluder: From Preclinical Investigations to First‐in‐Human Application

Cardiovascular Therapeutics, Volume 2026, Issue 1, 2026.
Objective This study was designed to first evaluate the histological compatibility of the split occluder in preclinical animal models, followed by clinical validation of its procedural feasibility and occlusion effectiveness in a first‐in‐human trial cohort. Methods Eight healthy labrador retrievers were selected for this study.
Mingfei Li, Dawei Lin, Lei Zhang, Yuan Zhang, Wenzhi Pan, Xiaochun Zhang, Daxin Zhou, Junbo Ge, Abhishesh Mehata   +8 more
wiley   +1 more source

Atrial tachyarrhythmias following percutaneous device closure of secundum atrial septal defects

International Journal of Cardiology: Heart & Vasculature, 2020
Background: Atrial tachyarrhythmias (ATs) are a major source of morbidity in the atrial septal defect (ASD) patient cohort. The optimal timing and approach of anti-arrhythmic intervention is currently unclear.
Vishal Vyas, Amit Kaura, Vinit Sawhney, Martin Lowe, Vivienne Ezzat   +4 more
doaj   +1 more source

A Decade of Experience With Transcatheter VSD Closure: Outcomes From a Philanthropic‐Based Center

Journal of Interventional Cardiology, Volume 2026, Issue 1, 2026.
Background Ventricular septal defects (VSDs) are the most common congenital heart defects, with outcomes influenced by size and location. Transcatheter closure (TCC) has become a widely used option for repair. This study presents a decade‐long institutional experience with TCC of VSDs, evaluating its safety and efficacy.
Ahmad Amer, Hanita Shai, Avital Mitler, Alona Raucher Sternfeld, Sagi Assa, Irfan Ahmad   +5 more
wiley   +1 more source

Safety and one-year follow-up analysis of percutaneous ASD closure at a tertiary care hospital

Indian Heart Journal
Aim: This study was designed to evaluate the safety and effectiveness of the Cocoon Septal Occluder device (Vascular Innovations Co. Nonthaburi, Thailand) for transcatheter closure of isolated secundum type atrial septal defect (ASD) in Indian patients ...
Naga Raghunandan Thota, Kamalakar Kosaraju, John Satish Rudrapogu, Krishna Prasad Nevali, Thirupathi Rao Kondaveeti   +4 more
doaj   +1 more source

Feasibility of percutaneous closure of atrial septal defects in adults under transthoracic echocardiography guidance using the Figulla atrial septal defect occluder device

Journal of the Saudi Heart Association, 2018
Background: Closure of atrial septal defect (ASD) among adults under transthoracic echocardiography (TTE) guidance using devices other than the Amplatzer Septal Occluder has not been extensively tested.
Mahmoud Ali, Hesham Salah El-Din, Sameh Bakhoum, Amal El-Sisi, Kareem Mahmood, Heba Farouk, Hossam Kandil   +6 more
doaj   +1 more source